Search results
Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech
ABC News via Yahoo News· 2 years agoThe world could be only a few years away from a cancer vaccine, according to the couple behind the...
This Key Piece Of News Could Spark BioNTech, Moderna — And Stoke Demand For Covid Boosters
Investor's Business Daily· 1 year agoCovid vaccine stocks BioNTech and Moderna surged Friday after a new study suggested an added benefit...
Moderna accuses Pfizer/BioNTech of patent infringement over the tech behind its COVID vaccine
WFXT via Yahoo News· 2 years agoA legal battle is brewing between makers of vaccines against COVID-19. Cambridge-based Moderna is...
Is This Vaccine Stock a Buy After Big News?
Motley Fool· 2 years agoIt's hard to believe that more than two years after the onset of COVID-19 in the U.S., we're still seeing vaccines come to market. Of course, we...
Pfizer's 3-Dose COVID Vaccine Is 80% Effective in Kids Under 5
People via Yahoo News· 2 years agoPfizer and BioNTech are seeking emergency use authorization of its COVID vaccine for kids under 5...
The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 30, 2023 – Zacks.com announces the list of stocks...
Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorization
USA TODAY via Yahoo News· 2 years agoPfizer and German partner BioNTech have submitted their new COVID-19 booster – that targets the omicron subvariant BA.5 – to the Food and Drug Administration for emergency use authorization, ...
Pfizer, BioNTech ask FDA to approve omicron-targeting booster for kids ages 5-11
NY Daily News via AOL· 2 years agoPfizer on Monday became the latest COVID-19 vaccine manufacturer to seek federal approval for...
Get COVID-19 booster now — or wait for new vaccine formula? We asked the experts
Detroit Free Press via Yahoo News· 2 years agoPfizer and its German-based partner BioNTech applied this week to the U.S. Food and Drug...
New Pfizer data shows strong three-dose protection for youngest kids, company says
NBC Universal via AOL· 2 years agoThree doses of Pfizer-BioNTech’s Covid-19 vaccine for the youngest children were 80 percent...
